François Fay
- Biomaterials top 2%
- Molecular Biology
- Biomedical Engineering top 5%
- Immunology top 10%
- Pharmaceutical Science top 1%
- Co-authors
- Christopher J. ScottWillem J. M. MulderZahi A. FayadBrenda L. Sánchez-GaytánRyan F. DonnellyMark E. LobattoJun TangYongTae Kim
- Topics
- Nanoparticle-Based Drug Delivery (17 papers)RNA Interference and Gene Delivery (9 papers)Atherosclerosis and Cardiovascular Diseases (6 papers)
- Journals
- Proceedings of the National Academy of SciencesAngewandte Chemie International EditionNature Communications
- Partner nations
- United StatesFranceNetherlands
In The Last Decade
François Fay
35 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 98
- Biomaterials 611
- Molecular Biology 569
- Biomedical Engineering 553
- Immunology 362
- Pharmaceutical Science 311
Countries citing papers authored by François Fay
This map shows the geographic impact of François Fay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Fay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Fay more than expected).
Fields of papers citing papers by François Fay
This network shows the impact of papers produced by François Fay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Fay. The network helps show where François Fay may publish in the future.
Co-authorship network of co-authors of François Fay
This figure shows the co-authorship network connecting the top 25 collaborators of François Fay. A scholar is included among the top collaborators of François Fay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Fay. François Fay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 13 | |
| 9 | 39 | |
| 10 | 27 | |
| 11 | 34 | |
| 12 | 2 | |
| 13 | 66 | |
| 14 | 42 | |
| 15 | 115 | |
| 16 | 102 | |
| 17 | 48 | |
| 18 | 52 | |
| 19 | 67 | |
| 20 | 44 |
About François Fay
François Fay is a scholar working on Biomaterials, Pharmaceutical Science and Immunology, having authored 39 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (17 papers), RNA Interference and Gene Delivery (9 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). The work is most often cited by research in Pharmaceutical Science (311 citations), Biomaterials (611 citations) and Immunology (362 citations). François Fay has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Christopher J. Scott, Willem J. M. Mulder, Zahi A. Fayad, Brenda L. Sánchez-Gaytán, Ryan F. Donnelly, Mark E. Lobatto, Jun Tang, YongTae Kim, Róbert Langer and Derek J. Quinn. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.